Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Intuitive Surgical Back In Court On “Remote Location” Patent Dispute

This article was originally published in The Gray Sheet

Executive Summary

A federal appeals court decision to overturn an earlier ruling that Intuitive Surgical's da Vinci robotic surgery system did not infringe a patent held by Brookhill-Wilk complicates Intuitive's plan to settle outstanding patent litigation via acquisition

You may also be interested in...



Intuitive Surgical litigation concludes

Payment of one-time $2.6 mil. license fee to Brookhill-Wilk in exchange for permanent, exclusive patent license settles all pending litigation between the companies, Intuitive announces Jan. 14. The patent relates to Intuitive's da Vinci robotic surgery system (1"The Gray Sheet" April 21, 2003, p. 39)...

Intuitive Surgical litigation concludes

Payment of one-time $2.6 mil. license fee to Brookhill-Wilk in exchange for permanent, exclusive patent license settles all pending litigation between the companies, Intuitive announces Jan. 14. The patent relates to Intuitive's da Vinci robotic surgery system (1"The Gray Sheet" April 21, 2003, p. 39)...

Intuitive Surgical Purchase Of Computer Motion Alleviates Patent Issues

Intuitive Surgical is paying $63 mil. to settle litigation over key technology patents through its acquisition of rival robotic surgical system maker Computer Motion

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018240

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel